New Evidence, New Treatments: The Impact of Clinical Trials on GlaucomaManagement

Chicago-The decision of whether to treat glaucoma or ocular hypertensionshould be a mutual one reached by both ophthalmologist and patient. Thedecision should take into account the risk of visual loss as the resultof glaucoma over the patient's lifetime and the potential treatment benefits.The risk factors that are most important in deciding whether to treat patientsinclude the level of IOP, race, age, and family history of glaucoma. KuldevSingh, MD, discussed the individualized approach to patient treatment andall factors that need to be considered.